Maze Therapeutics MAZE
NASDAQ MAZE
$34.74 -0.17 (-0.49%)
As of: Nov 10, 2026 · 2:24 PM EST

Maze Therapeutics (MAZE) Enterprise Value (2025 - 2026)

Updated

Maze Therapeutics (MAZE) reported Enterprise Value of $1.25 billion for Q2 2026, up 355.3% from $273.51 million a year earlier and up 10.0% from the prior quarter.

Analysis

Maze Therapeutics (MAZE) Enterprise Value (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Maze Therapeutics' Enterprise Value came in at $166.94 million; for FY2025, it was $1.7 billion.

  • Five-year quarterly Enterprise Value spans a low of $20.83 million in Q1 2025 and a high of $1.7 billion in Q4 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.13 billion (Q1 2026), $1.7 billion (Q4 2025) and $862.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Maze Therapeutics 2.05 Bn 561.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.25 Bn
Mar 31, 2026 1.13 Bn
Dec 31, 2025 1.70 Bn
Sep 30, 2025 862.70 Mn
Jun 30, 2025 273.51 Mn
Mar 31, 2025 20.83 Mn
API Access

Maze Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=MAZE&period=max&api_key=YOUR_API_KEY